Running for Myself

Ashley Ericksen

A lot of things scare me. Right now, those things include my first 20-mile run of marathon training that I have this weekend and sharing this post. That’s the thing with fears, though. Embracing them usually makes you stronger.

How to Use the Online Program Planner

Online Program Planner

The ADAA Online Program Planner is a searchable directory that allows you to review the abstract, learning objectives, and speakers for every session of the conference. Search for sessions by category, topic, presenter, date and time to create an individual program based on your interests, which you can save and print out as your own itinerary. A printed final program will be available at the conference.

Mind Over Moods — Treating Coexisting Depression and Anxiety

Dennis Greenberger, PhD
Founder and Director
Anxiety & Depression Center
Newport Beach, California

Assistant Clinical Professor
Department of Psychiatry
University of California, Irvine, College of Medicine

Dr. Greenberger describes the differences and similarities between symptoms of anxiety and depression, how the disorders are treated, and what patients can expect in treatment.

Attaining and Maintaining Wellness in OCD (#6628)

Eligibility Criteria

You may be eligible if

  • You have OCD.
  • You are between the ages of 18 and 75.
  • You are still having bothersome symptoms while taking one of the medications listed below for OCD.
  • You are interested in receiving no-cost therapy treatment that may improve your symptoms so that you may be able to stop taking your medication.
  • Clomipramine (Anafranil)
  • Fluoxetine (Prozac)
  • Fluvoxamine (Luvox)
  • Sertraline (Zoloft)
  • Paroxetine (Paxil)
  • Citalopram (Celexa)
  • Escitalopram (Lexapro)
State
New York

A research study offering treatment for people who have obsessive-compulsive disorder (OCD) and are currently taking one of the following medications and still have unwanted symptoms:

  • Clomipramine (Anafranil)
  • Fluoxetine (Prozac)
  • Fluvoxamine (Luvox)
  • Sertraline (Zoloft)
  • Paroxetine (Paxil)
  • Citalopram (Celexa)
  • Escitalopram (Lexapro)

The goal of the study is to understand whether patients with OCD on serotonin reuptake inhibitors (SRIs) who achieve wellness from EX/RP can safely discontinue their medication.